CD8A and cancer: However, a majority of studies use antibodies targeted to key surface markers to broadly identify major TIL subsets in cancer such as CD20 (B cells), CD3 (T cells), CD4 & CD8 (T cells) and FOXP3 (Regulatory T cells or Treg) (12, 33, 47).